Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels.
about
Ca2+-dependent modulation of voltage-gated Ca2+ channelsLoss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafnessIon channels and transporters in lymphocyte function and immunityThe dynamic architecture of photoreceptor ribbon synapses: cytoskeletal, extracellular matrix, and intramembrane proteinsTowards a Unified Theory of Calmodulin Regulation (Calmodulation) of Voltage-Gated Calcium and Sodium ChannelsCaV channels and cancer: canonical functions indicate benefits of repurposed drugs as cancer therapeuticsDecreased temporal precision of neuronal signaling as a candidate mechanism of auditory processing disorderVoltage-Gated Cav1 Channels in Disorders of Vision and HearingVoltage-gated calcium channelsEmerging evidence for specific neuronal functions of auxiliary calcium channel α₂δ subunits.Dysregulation of Ca(v)1.4 channels disrupts the maturation of photoreceptor synaptic ribbons in congenital stationary night blindness type 2Age-related homeostatic midchannel proteolysis of neuronal L-type voltage-gated Ca²⁺ channels.Spectrum of Cav1.4 dysfunction in congenital stationary night blindness type 2L-type calcium channels play a critical role in maintaining lens transparency by regulating phosphorylation of aquaporin-0 and myosin light chain and expression of connexinsChannelopathies: summary of the hot topic keynotes sessionFunctional properties of a newly identified C-terminal splice variant of Cav1.3 L-type Ca2+ channelsCalcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine.Calcineurin Controls Voltage-Dependent-Inactivation (VDI) of the Normal and Timothy Cardiac Channels.Levels of Ca(V)1.2 L-Type Ca(2+) Channels Peak in the First Two Weeks in Rat Hippocampus Whereas Ca(V)1.3 Channels Steadily Increase through Development.The expression of whirlin and Cav1.3α₁ is mutually independent in photoreceptors.Ion channels in innate and adaptive immunityGDF-15 enhances intracellular Ca2+ by increasing Cav1.3 expression in rat cerebellar granule neurons.What can naturally occurring mutations tell us about Ca(v)1.x channel function?A naturally occurring truncated Cav1.2 α1-subunit inhibits Ca2+ current in A7r5 cells.Orais and STIMs: physiological mechanisms and diseasePhotoreceptor degeneration in two mouse models for congenital stationary night blindness type 2Presynaptic [Ca(2+)] and GCAPs: aspects on the structure and function of photoreceptor ribbon synapses.How voltage-gated calcium channels gate forms of homeostatic synaptic plasticitySignaling complexes of voltage-gated calcium channelsNovel insights into the pathomechanisms of skeletal muscle channelopathies.Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS.EF hand-mediated Ca- and cGMP-signaling in photoreceptor synaptic terminals.L-type CaV1.2 calcium channels: from in vitro findings to in vivo function.Biophysics, pathophysiology, and pharmacology of ion channel gating pores.Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.Decalmodulation of Cav1 channels by CaBPs.C-terminal modulatory domain controls coupling of voltage-sensing to pore opening in Cav1.3 L-type Ca(2+) channels.Transcriptional regulation of voltage-gated Ca2+ channels.Retinal characteristics of the congenital disorder of glycosylation PMM2-CDG.Homeostatic synaptic depression is achieved through a regulated decrease in presynaptic calcium channel abundance.
P2860
Q21564049-1922FE43-C166-4D91-9666-5AD6FEB04EB3Q24311948-FB93BC5E-067E-4C28-9017-AA21AF087618Q26829714-526E0302-B9F8-40DF-9F66-58EDC995F0FAQ26865168-1D131B14-2720-44FB-B02A-EC68B60D8806Q27002550-CC525EBB-45A5-4CCE-AC7A-67BA2649BB17Q28078594-709ACB4B-9EA4-404E-BCC3-C00AFB7C6D6BQ28081905-D5C6EFD0-2DC6-4ADE-AB65-F78DC3BDAC1CQ28084651-D0E26802-8C76-43F0-9261-01D91A6DE58EQ28242997-6DADCABD-8D5E-4688-9622-0003F35C346FQ30407837-F9AAEDD9-3788-4AE7-B593-5E1F0516301CQ33702563-0E9E775F-C9B1-491D-86C9-534F2A1C1E1AQ33736402-55ACB44D-C2E6-434E-A859-30DA05293D51Q33786236-A9771FD5-B52F-4F37-B6CF-A57D1BF68AF1Q34755622-2728BCB5-49EC-459A-B735-4BA7EB3E4DFAQ35434773-8EAE2B35-B778-42E2-A479-6EFEF3AD541EQ35604964-3FD8E75C-3607-425B-9B4B-6140CC2AD2ACQ35743824-4BA058BB-46DF-4E9C-94F2-73D54247C232Q35893283-48A5C998-8EBF-4AF2-807C-522D28A131A8Q36337465-BAAA0E6C-B6DE-4499-B320-9912ADA2E17AQ36445845-3D9E280F-2129-40CB-9F68-879EBF17C021Q36769825-A4436E47-6333-478C-B257-8513FC4A8ED1Q37047659-9A2E6100-6970-4181-A0CA-78A459181EB0Q37209113-035FDE12-E4E2-4554-B086-B2DD9C99EA21Q37234587-ED6AB1DE-7BF0-4B05-9FBE-4A4E27B036F7Q37294792-185F2F0F-4727-4982-85DA-469646840154Q37500609-1D6A9EE2-BB1D-48DF-8A47-44B0B359291FQ37559115-192EC1F8-9787-4070-B275-0E2605C380E4Q37584846-79D124D8-ADCB-4186-884F-219B93275AB1Q37915192-BD1C38D6-EF07-4831-BDCA-84041ED1E8DBQ37956141-D5166ED2-70C2-4123-8413-D5F34FD89212Q37976377-6338F2F3-8781-4756-80B7-1140EEC7CAB2Q37990913-BA371E66-345D-45B1-B9A2-4AC87B906888Q38175138-ED187231-2CBC-4C54-B1D2-2D96C8BE3566Q38207583-33C7FDB7-FC48-4A04-ACE0-8BD98422DACFQ38329774-ECA97D9E-B3EB-4156-9397-557C62EF9CA6Q38544089-A93B7D06-E4B7-4F3D-B2A5-BF3F1A11A22BQ38623048-AB44E5C4-117D-4447-A29C-3BD0DE61D544Q39216739-1D017F8D-C3D4-4C33-B1FA-75E819C59592Q39463521-70634510-DD5D-4D26-86FB-375AB8DF7FC2Q41073181-6B3E3332-59DF-4F9C-A341-88674D0B8CB3
P2860
Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels.
@en
Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels.
@nl
type
label
Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels.
@en
Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels.
@nl
prefLabel
Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels.
@en
Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels.
@nl
P2860
P921
P1433
P1476
Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels.
@en
P2093
Alexandra Koschak
Jörg Striessnig
P2860
P2888
P304
P356
10.1007/S00424-010-0800-X
P577
2010-03-07T00:00:00Z
2010-07-01T00:00:00Z